Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Ibio ( (IBIO) ) just unveiled an update.
On July 29, 2025, iBio, Inc. received a notice from Nasdaq indicating that its common stock had not met the minimum closing bid price of $1.00 per share for 30 consecutive business days. This notice does not immediately affect the company’s stock listing, and iBio has until January 26, 2026, to regain compliance. The company plans to monitor its stock price and may consider actions such as a reverse stock split to meet Nasdaq’s requirements and maintain its listing.
The most recent analyst rating on (IBIO) stock is a Buy with a $5.00 price target. To see the full list of analyst forecasts on Ibio stock, see the IBIO Stock Forecast page.
Spark’s Take on IBIO Stock
According to Spark, TipRanks’ AI Analyst, IBIO is a Neutral.
IBIO’s overall score is heavily impacted by significant financial challenges, including negative earnings and cash flow issues. The weak technical outlook and poor valuation metrics further weigh down the score. However, recent strategic corporate events provide some optimism for future growth, but they are not enough to offset the current financial difficulties.
To see Spark’s full report on IBIO stock, click here.
More about Ibio
Average Trading Volume: 2,122,918
Technical Sentiment Signal: Sell
Current Market Cap: $11.03M
For an in-depth examination of IBIO stock, go to TipRanks’ Overview page.